Copyright Reports & Markets. All rights reserved.

Global Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Recombinant Vaccines
      • 1.2.2 Viral Vaccines
      • 1.2.3 Polysaccharide Vaccines
      • 1.2.4 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Cholera
      • 1.3.2 Hepatitis B
      • 1.3.3 Diphtheria
      • 1.3.4 Tetanus
      • 1.3.5 Measles vaccine
      • 1.3.6 Hepatitis A
      • 1.3.7 Live attenuated influenza vaccine
      • 1.3.8 Polio vaccine
      • 1.3.9 Rabies vaccine
      • 1.3.10 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GSK
      • 2.1.1 Business Overview
      • 2.1.2 Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GSK Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Merck
      • 2.3.1 Business Overview
      • 2.3.2 Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Merck Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Pfizer
      • 2.4.1 Business Overview
      • 2.4.2 Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Pfizer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Novartis(GSK)
      • 2.5.1 Business Overview
      • 2.5.2 Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 CSL
      • 2.6.1 Business Overview
      • 2.6.2 Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 CSL Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 MedImmune LLC
      • 2.7.1 Business Overview
      • 2.7.2 Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 MedImmune LLC Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 J&J(Crucell)
      • 2.8.1 Business Overview
      • 2.8.2 Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 J&J(Crucell) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 China National Biotec
      • 2.9.1 Business Overview
      • 2.9.2 Vaccines Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 China National Biotec Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Tiantan
      • 2.10.1 Business Overview
      • 2.10.2 Vaccines Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Tiantan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Hualan
      • 2.11.1 Business Overview
      • 2.11.2 Vaccines Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Hualan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Kangtai
      • 2.12.1 Business Overview
      • 2.12.2 Vaccines Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Kangtai Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Hissen
      • 2.13.1 Business Overview
      • 2.13.2 Vaccines Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Hissen Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Jintan
      • 2.14.1 Business Overview
      • 2.14.2 Vaccines Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Jintan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Vaccines Market Analysis by Regions

    • 4.1 Global Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Vaccines Sales and Growth Rate (2014-2019)

    5 North America Vaccines by Country

    • 5.1 North America Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Vaccines Sales and Growth Rate (2014-2019)

    6 Europe Vaccines by Country

    • 6.1 Europe Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Vaccines by Country

    • 7.1 Asia-Pacific Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Vaccines Sales and Growth Rate (2014-2019)

    8 South America Vaccines by Country

    • 8.1 South America Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Vaccines by Countries

    • 9.1 Middle East and Africa Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Vaccines Sales and Growth Rate (2014-2019)

    10 Global Vaccines Market Segment by Type

    • 10.1 Global Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Recombinant Vaccines Sales Growth and Price
      • 10.2.1 Global Recombinant Vaccines Sales Growth (2014-2019)
      • 10.2.2 Global Recombinant Vaccines Price (2014-2019)
    • 10.3 Viral Vaccines Sales Growth and Price
      • 10.3.1 Global Viral Vaccines Sales Growth (2014-2019)
      • 10.3.2 Global Viral Vaccines Price (2014-2019)
    • 10.4 Polysaccharide Vaccines Sales Growth and Price
      • 10.4.1 Global Polysaccharide Vaccines Sales Growth (2014-2019)
      • 10.4.2 Global Polysaccharide Vaccines Price (2014-2019)
    • 10.5 Others Sales Growth and Price
      • 10.5.1 Global Others Sales Growth (2014-2019)
      • 10.5.2 Global Others Price (2014-2019)

    11 Global Vaccines Market Segment by Application

    • 11.1 Global Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Cholera Sales Growth (2014-2019)
    • 11.3 Hepatitis B Sales Growth (2014-2019)
    • 11.4 Diphtheria Sales Growth (2014-2019)
    • 11.5 Tetanus Sales Growth (2014-2019)
    • 11.6 Measles vaccine Sales Growth (2014-2019)
    • 11.7 Hepatitis A Sales Growth (2014-2019)
    • 11.8 Live attenuated influenza vaccine Sales Growth (2014-2019)
    • 11.9 Polio vaccine Sales Growth (2014-2019)
    • 11.10 Rabies vaccine Sales Growth (2014-2019)
    • 11.11 Others Sales Growth (2014-2019)

    12 Vaccines Market Forecast (2019-2024)

    • 12.1 Global Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Vaccines Market Forecast (2019-2024)
    • 12.3 Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

      Scope of the Report:
      Vaccines can be divided into recombinant vaccines, viral vaccines, polysaccharide vaccines and others. Recombinant vaccines and viral vaccines contain many kinds of vaccines, and the demand is larger than others kinds. But with the development of new technologies, more and more new types of vaccines will be popularized. The scope for disease prevention will be enlarged .The demand of other kinds is also increasing.
      China is the fastest growing Vaccines market in the world thanks to positive policy and increasing market awareness.
      Average industry gross margin is about 76.95%. But due to high requirement for funds and technology, before investment you'd better take a deep consideration. So far many large companies choose cooperation or acquisition to achieve the expansion of business.
      The worldwide market for Vaccines is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 50900 million US$ in 2024, from 35400 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      GSK
      Sanofi
      Merck
      Pfizer
      Novartis(GSK)
      CSL
      MedImmune LLC
      J&J(Crucell)
      China National Biotec
      Tiantan
      Hualan
      Kangtai
      Hissen
      Jintan

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Recombinant Vaccines
      Viral Vaccines
      Polysaccharide Vaccines
      Others

      Market Segment by Applications, can be divided into
      Cholera
      Hepatitis B
      Diphtheria
      Tetanus
      Measles vaccine
      Hepatitis A
      Live attenuated influenza vaccine
      Polio vaccine
      Rabies vaccine
      Others

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Vaccines product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Vaccines, with price, sales, revenue and global market share of Vaccines in 2017 and 2018.
      Chapter 3, the Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now